Tiotropium Bromide/Olodaterol (Stiolto Respimat): Once-Daily Combination Therapy for the Maintenance of COPD

類似資料

• Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation
  著者:: S. V. Nedogoda, 等
  出版事項: (2020-08-01)
• Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation
  著者:: S. V. Nedogoda, 等
  出版事項: (2020-08-01)
• The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects
  著者:: Derom, Eric, 等
  出版事項: (2019)
• The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study)
  著者:: Beeh, Kai-Michael, 等
  出版事項: (2016)
• Efficacy of tiotropium–olodaterol fixed-dose combination in COPD
  著者:: Derom, Eric, 等
  出版事項: (2016)